44
Informaciones
Psiquiátricas
2016 - n.º 226
18. Roche F, Foster P. Cannabinoid Hypere-
mesis: not just a problem in Adelaide
Hills. Gut 2005; 54:727-734.
19. Roelofs, Vorel, Vorel-Havelkova y Brom-
bacher-Heerlen.
20. Sannarangappa V, Tan C. Cannabinoid
hyperemesis. Internal Medicine Journal
2009; 39:777–778.
21. Singh y Coyle, 2008.
22. Torka P, Sharma R. Cannabinoid and
hyperemesis. Mayo Clinic Proceedings
2012; 87:502–503.
23. Wolfhagen-Tillburg F H J. Cannabinoïd
hyperemesis met als bijzonder verschijn-
seldwangmatigwarmbaden. Nederlands
Tijdschrift Voor Geneeskunde 2004;
2005:2–3.
24. Francis H. Emerging role of chronic
cannabis usage and hyperemesis syn-
drome. Southern Medical Journal 2011;
104:665.
25. Sullivan S. Cannabinoid hyperemesis,
The Canadian Journal of Gastroenterolo-
gy 2012; 24:284–285.
26. Mohammed, Panchoo, Bartholemew, Ma-
haraj, 2013.
27. Cox B, Chhabra A, Adler M, Simmons J,
Randlett D. Cannabinoid hyperemesis
syndrome: case report of a paradoxical
reaction with heavy marijuana use. Case
Reports in Medicine 2012; 2012:757-96.
28. Kraemer R R, La Hoz R M, Willig J H.
Some like it hot: erythema ab igne
due to cannabinoid hyperemesis. Jour-
nal of General Internal Medicine 2013;
28:1522.
29. Habboushe J, Sedor J. Cannabinoid hy-
peremesis acute renal failure: a com-
mon sequela of cannabinoid hypereme-
sis syndrome. The American Journal of
Emergency Medicine 2014.
30. Chang Y H, Windish D M. Cannabinoid
hyperemesis relieved by compulsive
bathing., Mayo ClinicProceedings 2009;
84:76–78.
31. Alameda-Bailén J R, Salguero-Alcañiz M
P, Merchán-Clavellino A, Paíno-Quesada
S. Mecanismos cognitivos en la toma de
decisiones arriesgadas en consumidores
de cannabis. Adicciones 2014; 26:146–
158.
32. Darmani, N.A. The potent emetogenic
effects of the endocannabinoid, 2A-G
(2-Arachidonoyglycerol) are blocked by
D9-Tetrahydrocannabinol and other can-
nabinoids. The Journal of Pharmacol and
Experimental Therapeutics 2002; 300:
34-42.
Carla Contreras Narváez
